About
Cordis is a global medical device company that specializes in developing and manufacturing high-quality, minimally invasive technologies for cardiovascular and endovascular care. Founded in 1957 by Dr. William P. Murphy Jr. in Miami, Florida, Cordis has a rich history of innovation in interventional vascular medicine and neuroscience, focusing on treating coronary and peripheral vascular diseases. With headquarters in Baar, Switzerland, and Santa Clara, California, Cordis operates internationally, serving markets in Europe, Africa, the Middle East, North America, Asia-Pacific, and Latin America. The company offers a range of medical devices for diagnostic and interventional procedures, including angioplasty balloons, stents, sheath introducers with hemostasis valves, and electrophysiology devices. Cordis has been a pioneer in the field, introducing the first sheath introducers with hemostasis valves and the first remotely programmable pacemaker. Its products are marketed to healthcare providers, hospitals, and specialists involved in cardiovascular diagnostics and interventions worldwide.
Technologies
Keywords
Company Information
-
Employees 4200
-
Founded 1957
-
Annual Revenue $790545000
Location
14201 NW 60th Ave, Miami Lakes, Florida, United States, 33014-2802